BICO Group AB (publ) (OTCMKTS:CLLKF) Sees Significant Decline in Short Interest

BICO Group AB (publ) (OTCMKTS:CLLKF) was the target of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 1,313 shares, a decrease of 88.5% from the January 15th total of 11,371 shares. Based on an average trading volume of 1,411 shares, the days-to-cover ratio is currently 0.9 days. Based on an average trading volume of 1,411 shares, the days-to-cover ratio is currently 0.9 days.

BICO Group AB (publ) Stock Performance

OTCMKTS:CLLKF remained flat at C$1.98 during mid-day trading on Tuesday. BICO Group AB has a 12 month low of C$1.88 and a 12 month high of C$4.21. The stock has a 50 day simple moving average of C$2.12 and a 200-day simple moving average of C$2.46.

About BICO Group AB (publ)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.